Chronic Pain Management: An Overview of Taxonomy, Conditions Commonly Encountered, and Assessment

Medical Clinics of North America

Volumn 100, Issue 1, 2016, Pages 1-16

  Walk, David ^a   Poliak Tunis, Michelle ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Chronic pain; Mechanisms of pain; Pain assessment

Indexed keywords

OPIATE;

ANXIETY ASSESSMENT; BRIEF PAIN INVENTORY; CANCER PAIN; CHRONIC PAIN; COMORBIDITY; DIABETIC NEUROPATHY; DIAGNOSIS, INTRACTABILITY, RISK, EFFICACY SCORE; DISEASE CLASSIFICATION; DOULEUR NEUROPATHIQUE 4 QUESTIONNAIRE; DRUG DEPENDENCE; DRUG MISUSE; FIBROMYALGIA; HEADACHE; HUMAN; INDIVIDUAL BEHAVIOR ASSESSMENT; MCGILL PAIN QUESTIONNAIRE; MUSCULOSKELETAL PAIN; MYOFASCIAL PAIN; NEUROPATHIC PAIN; NEUROPATHIC PAIN QUESTIONNAIRE; NEUROPATHIC PAIN SCALE; NOCICEPTION; OPIOID RISK TOOL; OSWESTRY DISABILITY INDEX; PAIN ANXIETY SYMPTOMS SCALE; PAIN ASSESSMENT; PAIN CATASTROPHIZING SCALE; PAIN SEVERITY; PELVIC PAIN; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RATING SCALE; REVIEW; RISK BENEFIT ANALYSIS; SCREENER AND OPIOID ASSESSMENT FOR PATIENTS WITH PAIN; SPINAL PAIN; TACHYPHYLAXIS; TAXONOMY; TRIGEMINUS NEURALGIA; UNSPECIFIED SIDE EFFECT; VISCERAL PAIN; VISUAL ANALOG SCALE; ADAPTIVE BEHAVIOR; ANALGESIA; CLASSIFICATION; INTERDISCIPLINARY COMMUNICATION; MULTIMODALITY CANCER THERAPY; PAIN MEASUREMENT; PROCEDURES;

ADAPTATION, PSYCHOLOGICAL; CHRONIC PAIN; COMBINED MODALITY THERAPY; HUMANS; INTERDISCIPLINARY COMMUNICATION; PAIN MANAGEMENT; PAIN MEASUREMENT;

EID: 84952863271     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2015.09.005     Document Type: Review

References (53)

1. Tsang A., Von Korff M., Lee S., et al. Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders. J Pain 2008, 9(10):883-891.
2. GBD 2010 Heat Map. 2015. Available at: . Accessed May 13, 2015. http://vizhub.healthdata.org/irank/heat.php.
3. Gaskin D.J., Richard P. The economic costs of pain in the United States. J Pain 2012, 13(8):715-724.
4. Institute of Medicine. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. 2011. Available at: . Accessed May 11, 2015. https://www.iom.edu/Reports/2011/Relieving-Pain-in-America-A-Blueprint-for-Transforming-Prevention-Care-Education-Research.aspx.
5. IASP taxonomy. 1994. Available at: . Accessed April 06, 2015. http://iasp-pain.org/Taxonomy?navItemNumber=576#Pain.
6. Almeida T.F., Roizenblatt S., Tufik S. Afferent pain pathways: a neuroanatomical review. Brain Res 2004, 1000(1-2):40-56.
7. Berthier M., Starkstein S., Leiguarda R. Asymbolia for pain: a sensory-limbic disconnection syndrome. Ann Neurol 1988, 24(1):41-49.
8. Keszthelyi D., Troost F.J., Masclee A.A. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2012, 303(2):G141-G154.
9. Williams D.A., Gracely R.H. Biology and therapy of fibromyalgia. Functional magnetic resonance imaging findings in fibromyalgia. Arthritis Res Ther 2006, 8(6):224.
10. Costigan M., Scholz J., Woolf C.J. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 2009, 32:1-32.
11. Young E.E., Lariviere W.R., Belfer I. Genetic basis of pain variability: recent advances. J Med Genet 2012, 49(1):1-9.
12. Bali K.K., Kuner R. Noncoding RNAs: key molecules in understanding and treating pain. Trends Mol Med 2014, 20(8):437-448.
13. Topics and Codes. Topics and Codes. Available at: . Accessed May 06, 2015. http://www.iasp-pain.org/files/Content/ContentFolders/Publications2/ClassificationofChronicPain/Part_I-Scheme+Topics.pdf.
14. LaMotte R.H., Thalhammer J.G., Torebjork H.E., et al. Peripheral neural mechanisms of cutaneous hyperalgesia following mild injury by heat. J Neurosci 1982, 2(6):765-781.
15. Janig B.R. The role of the sympathetic nervous system in pain processing. The pain system in normal and pathological states: a primer for clinicians 2004, 193-210. IASP Press, Seattle (WA). 1st edition.
16. Neumann S., Doubell T.P., Leslie T., et al. Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature 1996, 384(6607):360-364.
17. Milligan E.D., Watkins L.R. Pathological and protective roles of glia in chronic pain. Nature reviews. Neuroscience 2009, 10(1):23-36.
18. Reynolds D.V. Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science 1969, 164(3878):444-445.
19. Fields H. State-dependent opioid control of pain. Nature reviews. Neuroscience 2004, 5(7):565-575.
20. Karl A., Birbaumer N., Lutzenberger W., et al. Reorganization of motor and somatosensory cortex in upper extremity amputees with phantom limb pain. J Neurosci 2001, 21(10):3609-3618.
21. Alfonso Romero-Sandoval E., Sweitzer S. Nonneuronal central mechanisms of pain: glia and immune response. Prog Mol Biol Translational Sci 2015, 131:325-358.
22. Treede R.D., Jensen T.S., Campbell J.N., et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008, 70(18):1630-1635.
23. Bouhassira D., Attal N., Alchaar H., et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005, 114(1-2):29-36.
24. Krause S.J., Backonja M.M. Development of a neuropathic pain questionnaire. Clin J Pain 2003, 19(5):306-314.
25. Julien N., Goffaux P., Arsenault P., et al. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 2005, 114(1-2):295-302.
26. Staud R., Robinson M.E., Vierck C.J., et al. Diffuse noxious inhibitory controls (DNIC) attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients. Pain 2003, 101(1-2):167-174.
27. Lopez-Sola M., Pujol J., Wager T.D., et al. Altered functional magnetic resonance imaging responses to nonpainful sensory stimulation in fibromyalgia patients. Arthritis Rheumatol 2014, 66(11):3200-3209.
28. Niddam D.M., Chan R.C., Lee S.H., et al. Central representation of hyperalgesia from myofascial trigger point. Neuroimage 2008, 39(3):1299-1306.
29. Kuan T.S. Current studies on myofascial pain syndrome. Curr Pain Headache Rep 2009, 13(5):365-369.
30. Boden S.D., McCowin P.R., Davis D.O., et al. Abnormal magnetic-resonance scans of the cervical spine in asymptomatic subjects. A prospective investigation. J Bone Jointt Surg 1990, 72(8):1178-1184.
31. Bouwense S.A., de Vries M., Schreuder L.T., et al. Systematic mechanism-orientated approach to chronic pancreatitis pain. World J Gastroenterol 2015, 21(1):47-59.
32. Brandesi S., Mayer E.A. Irritable bowel syndrome. Science of pain 2009, Elsevier, Boston.
33. Benzon H.T. Essentials of pain medicine 2011, Elsevier/Saunders, Philadelphia. 3rd edition.
34. Assessment and management of chronic pain. 2013. Available at: . Accessed May 12, 2015. https://www.icsi.org/guidelines__more/catalog_guidelines_and_more/catalog_guidelines/catalog_neurological_guidelines/pain/.
35. Makris U.E., Higashi R.T., Marks E.G., et al. Ageism, negative attitudes, and competing co-morbidities - why older adults may not seek care for restricting back pain: a qualitative study. BMC Geriatr 2015, 15:39.
36. Kadimpati S., Zale E.L., Hooten M.W., et al. Associations between Neuroticism and depression in relation to catastrophizing and pain-related anxiety in chronic pain patients. PLoS One 2015, 10(4). e0126351.
37. Pizzo P.A., Clark N.M. Alleviating suffering 101-pain relief in the United States. N Engl J Med 2012, 366(3):197-199.
38. Matthias M.S., Krebs E.E., Bergman A.A., et al. Communicating about opioids for chronic pain: a qualitative study of patient attributions and the influence of the patient-physician relationship. Eur J Pain 2014, 18(6):835-843.
39. Dima A., Lewith G.T., Little P., et al. Patients' treatment beliefs in low back pain: development and validation of a questionnaire in primary care. Pain 2015, 156(8):1489-1500.
40. Hjermstad M.J., Fayers P.M., Haugen D.F., et al. Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage 2011, 41(6):1073-1093.
41. Kelly K.G., Cook T., Backonja M.M. Pain ratings at the thresholds are necessary for interpretation of quantitative sensory testing. Muscle Nerve 2005, 32(2):179-184.
42. Farrar J.T., Portenoy R.K., Berlin J.A., et al. Defining the clinically important difference in pain outcome measures. Pain 2000, 88(3):287-294.
43. Melzack R, Stein C, Mendl G. The McGill pain questionnaire. Available at: . Accessed May 12, 2015. http://www.cebp.nl/?NODE=77&SUBNODE=1136.
44. Atkinson T.M., Rosenfeld B.D., Sit L., et al. Using confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI). J Pain Symptom Manage 2011, 41(3):558-565.
45. Cleeland C.S. Brief pain inventory 1991, Pain Inventory, Available at:, Accessed May 12, 2015. http://www.mdanderson.org/education-and-research/departments-programs-and-labs/departments-and-divisions/symptom-research/symptom-assessment-tools/brief-pain-inventory.html.
46. Gronblad M., Hupli M., Wennerstrand P., et al. Intercorrelation and test-retest reliability of the Pain Disability Index (PDI) and the Oswestry Disability Questionnaire (ODQ) and their correlation with pain intensity in low back pain patients. Clin J Pain 1993, 9(3):189-195.
47. Galer B.S., Jensen M.P. Development and preliminary validation of a pain measure specific to neuropathic pain: the neuropathic pain scale. Neurology 1997, 48(2):332-338.
48. Moore T.M., Jones T., Browder J.H., et al. A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management. Pain Med 2009, 10(8):1426-1433.
49. Butler S. The screener and opioid assessment for patients with pain (SOAPP). New Hampshire Medical Society.
50. LR W. Opiod Risk Tool. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool. 2005. Available at: . Accessed May 11, 2015. http://www.opioidrisk.com/node/1203.
51. Belgrade M.J., Schamber C.D., Lindgren B.R. The DIRE score: predicting outcomes of opioid prescribing for chronic pain. J Pain 2006, 7(9):671-681.
52. McCracken L.M., Zayfert C., Gross R.T. The pain anxiety symptoms scale: development and validation of a scale to measure fear of pain. Pain 1992, 50(1):67-73.
53. Sullivan M.J.L., Bishop S., Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess 1995, 7:524-532.